JP5837616B2 - アゴメラチン合成のための方法及び中間体 - Google Patents

アゴメラチン合成のための方法及び中間体 Download PDF

Info

Publication number
JP5837616B2
JP5837616B2 JP2013547894A JP2013547894A JP5837616B2 JP 5837616 B2 JP5837616 B2 JP 5837616B2 JP 2013547894 A JP2013547894 A JP 2013547894A JP 2013547894 A JP2013547894 A JP 2013547894A JP 5837616 B2 JP5837616 B2 JP 5837616B2
Authority
JP
Japan
Prior art keywords
formula
compound
synthesis
cyclization
subjected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013547894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014509309A (ja
Inventor
ザール，サミール
シレ，ベアトリス
ブーメディアン，メディ
Original Assignee
レ ラボラトワール セルヴィエ
レ ラボラトワール セルヴィエ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44088993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5837616(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by レ ラボラトワール セルヴィエ, レ ラボラトワール セルヴィエ filed Critical レ ラボラトワール セルヴィエ
Publication of JP2014509309A publication Critical patent/JP2014509309A/ja
Application granted granted Critical
Publication of JP5837616B2 publication Critical patent/JP5837616B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2013547894A 2011-01-05 2012-01-04 アゴメラチン合成のための方法及び中間体 Active JP5837616B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1100024A FR2970000B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine
FR1100024 2011-01-05
PCT/FR2012/000005 WO2012113999A1 (fr) 2011-01-05 2012-01-04 Procede et intermediaires de synthese de l ' agomelatine

Publications (2)

Publication Number Publication Date
JP2014509309A JP2014509309A (ja) 2014-04-17
JP5837616B2 true JP5837616B2 (ja) 2015-12-24

Family

ID=44088993

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013547894A Active JP5837616B2 (ja) 2011-01-05 2012-01-04 アゴメラチン合成のための方法及び中間体

Country Status (43)

Country Link
US (2) USRE46218E1 (zh)
EP (1) EP2661422B9 (zh)
JP (1) JP5837616B2 (zh)
KR (1) KR101543432B1 (zh)
CN (1) CN103313965B (zh)
AP (1) AP3609A (zh)
AR (1) AR084780A1 (zh)
AU (1) AU2012220474B2 (zh)
BR (1) BR112013017307A2 (zh)
CA (1) CA2823587C (zh)
CL (1) CL2013001882A1 (zh)
CO (1) CO6731101A2 (zh)
CR (1) CR20130301A (zh)
CU (1) CU24289B1 (zh)
CY (1) CY1117774T1 (zh)
DK (1) DK2661422T3 (zh)
EA (1) EA022077B1 (zh)
EC (1) ECSP13012735A (zh)
ES (1) ES2583682T3 (zh)
FR (1) FR2970000B1 (zh)
GE (1) GEP20156365B (zh)
HK (1) HK1189571A1 (zh)
HR (1) HRP20160713T1 (zh)
HU (1) HUE028471T2 (zh)
IL (1) IL227281A (zh)
JO (1) JO3200B1 (zh)
ME (1) ME02408B (zh)
MX (1) MX2013007837A (zh)
MY (1) MY162977A (zh)
NI (1) NI201300062A (zh)
PE (1) PE20140037A1 (zh)
PL (1) PL2661422T3 (zh)
RS (1) RS54753B9 (zh)
RU (1) RU2550812C2 (zh)
SA (1) SA112330134B1 (zh)
SG (1) SG191733A1 (zh)
SI (1) SI2661422T1 (zh)
TN (1) TN2013000274A1 (zh)
TW (1) TWI438180B (zh)
UA (1) UA104122C2 (zh)
UY (1) UY33845A (zh)
WO (1) WO2012113999A1 (zh)
ZA (1) ZA201305027B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058879B (zh) * 2012-12-20 2015-09-09 安徽悦康凯悦制药有限公司 阿戈美拉汀的制备方法
CN103804232B (zh) * 2014-01-26 2015-08-19 江西同和药业股份有限公司 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用
CN107353229B (zh) * 2017-08-08 2019-04-30 许昌恒生制药有限公司 一种阿戈美拉汀中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866334B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
CN101486665B (zh) 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法

Also Published As

Publication number Publication date
HUE028471T2 (en) 2016-12-28
WO2012113999A8 (fr) 2013-08-01
PE20140037A1 (es) 2014-02-01
UY33845A (es) 2012-07-31
FR2970000A1 (fr) 2012-07-06
CY1117774T1 (el) 2017-05-17
EA022077B1 (ru) 2015-10-30
SA112330134B1 (ar) 2014-08-25
SG191733A1 (en) 2013-08-30
EA201300794A1 (ru) 2014-02-28
USRE46218E1 (en) 2016-11-29
IL227281A (en) 2015-06-30
RS54753B9 (sr) 2019-09-30
RS54753B1 (sr) 2016-10-31
GEP20156365B (en) 2015-09-10
NI201300062A (es) 2013-12-11
ECSP13012735A (es) 2013-09-30
ZA201305027B (en) 2014-03-26
HK1189571A1 (zh) 2014-06-13
UA104122C2 (uk) 2013-12-25
US8853449B2 (en) 2014-10-07
CN103313965A (zh) 2013-09-18
SI2661422T1 (sl) 2016-08-31
DK2661422T3 (en) 2016-10-24
CA2823587C (fr) 2015-11-24
TN2013000274A1 (fr) 2014-11-10
ME02408B (me) 2016-09-20
EP2661422B9 (fr) 2016-09-07
ES2583682T3 (es) 2016-09-21
ES2583682T9 (es) 2016-10-31
JO3200B1 (ar) 2018-03-08
RU2013136344A (ru) 2015-02-10
CL2013001882A1 (es) 2013-12-06
MX2013007837A (es) 2013-09-06
CO6731101A2 (es) 2013-08-15
TWI438180B (zh) 2014-05-21
KR101543432B1 (ko) 2015-08-10
WO2012113999A1 (fr) 2012-08-30
US20130289307A1 (en) 2013-10-31
CU20130092A7 (es) 2013-08-29
RU2550812C2 (ru) 2015-05-20
AP2013007022A0 (en) 2013-07-31
AU2012220474B2 (en) 2015-08-20
BR112013017307A2 (pt) 2016-10-04
AR084780A1 (es) 2013-06-26
AU2012220474A1 (en) 2013-07-11
EP2661422B1 (fr) 2016-04-20
HRP20160713T1 (hr) 2016-07-29
MY162977A (en) 2017-07-31
CU24289B1 (es) 2017-12-08
FR2970000B1 (fr) 2013-01-04
CR20130301A (es) 2013-08-08
IL227281A0 (en) 2013-09-30
PL2661422T3 (pl) 2016-10-31
NZ612173A (en) 2015-08-28
JP2014509309A (ja) 2014-04-17
CN103313965B (zh) 2015-08-05
CA2823587A1 (fr) 2012-08-30
TW201309623A (zh) 2013-03-01
AP3609A (en) 2016-02-26
KR20130115345A (ko) 2013-10-21
EP2661422A1 (fr) 2013-11-13

Similar Documents

Publication Publication Date Title
KR101135336B1 (ko) 아고멜라틴의 합성 방법
JP5837616B2 (ja) アゴメラチン合成のための方法及び中間体
JP5837615B2 (ja) アゴメラチン合成のための新規方法
NZ612173B2 (en) Process and intermediates for synthesizing agomelatine
OA16477A (fr) Nouveau procédé de synthèse de l'agomélatine.
NZ612163B2 (en) New process for the synthesis of agomelatine
OA16476A (fr) Nouveau procédé de synthèse de l'agomélatine.

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150120

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150417

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151020

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151105

R150 Certificate of patent or registration of utility model

Ref document number: 5837616

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250